-
1 Comment
Krka d.d. is currently in a long term uptrend where the price is trading 9.2% above its 200 day moving average.
Krka d.d.'s total revenue rose by 281.2% to $2B since the same quarter in the previous year.
Its net income has increased by 299.0% to $291M since the same quarter in the previous year.
Finally, its free cash flow grew by 17.2% to $280M since the same quarter in the previous year.
Based on the above factors, Krka d.d. gets an overall score of 4/5.
| ISIN | SI0031102120 |
|---|---|
| CurrencyCode | PLN |
| Exchange | WAR |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector | Healthcare |
| Beta | 0.48 |
|---|---|
| PE Ratio | 9.21 |
| Market Cap | 16B |
| Dividend Yield | 5.3% |
| Target Price | 108.85 |
Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular diseases; the gastrointestinal tract; central nervous system; pain relief; anti-infectives; blood and blood-forming organs; urological; diabetes; and oncology. The company also provides non-prescription products, such as products for oral cavity and pharynx; cough and cold products; analgesics; nasal products; vitamin and mineral products; products for enhancing cerebral and peripheral circulation; products for enhancing digestive tract and digestion; health care products; and others. In addition, it offers animal health products comprising antiinfectives, antiparasitics, and other products for farm and companion animals. Further, the company provides health resort and tourist services. Krka, d. d. was founded in 1954 and is headquartered in Novo Mesto, Slovenia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for KRK.WAR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
